Mouse IFN-gamma ELISpot Development Module, 5 Plate | R&D Systems SEL485 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

R&D Systems

product type :

ELISA/assay

product name :

Mouse IFN-gamma ELISpot Development Module, 5 Plate

catalog :

SEL485

quantity :

1 Kit (for 5 Plates)

price :

615 USD

citations: 31

Reference
Chen J, Wu C, Chia M, Huang C, Chien M. A prospective CSFV-PCV2 bivalent vaccine effectively protects against classical swine fever virus and porcine circovirus type 2 dual challenge and prevents horizontal transmission. Vet Res. 2023;54:57 pubmed publisher
Schneider C, Taylor J, Sibilo M, Miura K, Mallory K, Mann C, et al. Orientation of Antigen Display on Self-Assembling Protein Nanoparticles Influences Immunogenicity. Vaccines (Basel). 2021;9: pubmed publisher
Tourlomousis P, Wright J, Bittante A, Hopkins L, Webster S, Bryant O, et al. Modifying bacterial flagellin to evade Nod-like Receptor CARD 4 recognition enhances protective immunity against Salmonella. Nat Microbiol. 2020;5:1588-1597 pubmed publisher
Santos S, Ramírez M, Miranda E, Reyes N, Martínez O, Acosta Santiago M, et al. Enhancement of Immune Responses by Guanosine-Based Particles in DNA Plasmid Formulations against Infectious Diseases. J Immunol Res. 2019;2019:3409371 pubmed publisher
Lee H, Jeong M, Oh J, Cho Y, Shen X, Stone J, et al. Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection. Sci Rep. 2017;7:43531 pubmed publisher
Abdel Fattah E, Bhattacharya A, Herron A, Safdar Z, Eissa N. Critical role for IL-18 in spontaneous lung inflammation caused by autophagy deficiency. J Immunol. 2015;194:5407-16 pubmed publisher
Assi H, Espinosa J, Suprise S, SOFRONIEW M, Doherty R, Zamler D, et al. Assessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBM. PLoS ONE. 2014;9:e96318 pubmed publisher
Muthumani K, Wise M, Broderick K, Hutnick N, Goodman J, Flingai S, et al. HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivo. PLoS ONE. 2013;8:e84234 pubmed publisher
Jorquera P, Choi Y, Oakley K, POWELL T, Boyd J, Palath N, et al. Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease. PLoS ONE. 2013;8:e74905 pubmed publisher
Kyutoku M, Nakagami H, Koriyama H, Nakagami F, Shimamura M, Kurinami H, et al. Inhibition of neointima formation through DNA vaccination for apolipoprotein(a): a new therapeutic strategy for lipoprotein(a). Sci Rep. 2013;3:1600 pubmed publisher
Papenfuss T, Powell N, McClain M, Bedarf A, Singh A, Gienapp I, et al. Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity. J Immunol. 2011;186:3346-55 pubmed publisher
Zheng X, de Paiva C, Li D, Farley W, Pflugfelder S. Desiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway. Invest Ophthalmol Vis Sci. 2010;51:3083-91 pubmed publisher
Kutzler M, Kraynyak K, Nagle S, Parkinson R, Zharikova D, Chattergoon M, et al. Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo. Gene Ther. 2010;17:72-82 pubmed publisher
Aravindaram K, Yu H, Lan C, Wang P, Chen Y, Chen H, et al. Transgenic expression of human gp100 and RANTES at specific time points for suppression of melanoma. Gene Ther. 2009;16:1329-39 pubmed publisher
Cao O, Hoffman B, Moghimi B, Nayak S, Cooper M, Zhou S, et al. Impact of the underlying mutation and the route of vector administration on immune responses to factor IX in gene therapy for hemophilia B. Mol Ther. 2009;17:1733-42 pubmed publisher
Kraynyak K, Kutzler M, Cisper N, Laddy D, Morrow M, Waldmann T, et al. Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo. Hum Gene Ther. 2009;20:1143-56 pubmed publisher
Muthumani K, Lankaraman K, Laddy D, Sundaram S, Chung C, Sako E, et al. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus. Vaccine. 2008;26:5128-34 pubmed publisher
Xiong W, Candolfi M, Kroeger K, Puntel M, Mondkar S, Larocque D, et al. Immunization against the transgene but not the TetON switch reduces expression from gutless adenoviral vectors in the brain. Mol Ther. 2008;16:343-51 pubmed publisher
Abdul Wahid A, Faubert G. Mucosal delivery of a transmission-blocking DNA vaccine encoding Giardia lamblia CWP2 by Salmonella typhimurium bactofection vehicle. Vaccine. 2007;25:8372-83 pubmed
Razafindratsita A, Saint Lu N, Mascarell L, Berjont N, Bardon T, Betbeder D, et al. Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation. J Allergy Clin Immunol. 2007;120:278-85 pubmed
Aiello F, Keller J, Klarmann K, Dranoff G, Mazzucchelli R, Durum S. IL-7 induces myelopoiesis and erythropoiesis. J Immunol. 2007;178:1553-63 pubmed
Huleatt J, Jacobs A, Tang J, Desai P, Kopp E, Huang Y, et al. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity. Vaccine. 2007;25:763-75 pubmed
Trabattoni D, Clivio A, Bray D, Bhagat L, Beltrami S, Maffeis G, et al. Immunization with gp120-depleted whole killed HIV immunogen and a second-generation CpG DNA elicits strong HIV-specific responses in mice. Vaccine. 2006;24:1470-7 pubmed
Kutzler M, Cao C, Bai Y, Dong H, Choe P, Saulino V, et al. Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice. Vaccine. 2006;24:4630-9 pubmed
Gardiner D, Huang Y, Basu S, Leung L, Song Y, Chen Z, et al. Multiple-site DNA vaccination enhances immune responses in mice. Vaccine. 2006;24:287-92 pubmed
De Groot A, McMurry J, Marcon L, Franco J, Rivera D, Kutzler M, et al. Developing an epitope-driven tuberculosis (TB) vaccine. Vaccine. 2005;23:2121-31 pubmed
De Palma R, Marigo I, Del Galdo F, De Santo C, Serafini P, Cingarlini S, et al. Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes. Cancer Res. 2004;64:8068-76 pubmed
Chattergoon M, Saulino V, Shames J, Stein J, Montaner L, Weiner D. Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice. Vaccine. 2004;22:1744-50 pubmed
Baum L, Blackall D, Arias Magallano S, Nanigian D, Uh S, Browne J, et al. Amelioration of graft versus host disease by galectin-1. Clin Immunol. 2003;109:295-307 pubmed
Chen L, Wang J, Zganiacz A, Xing Z. Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis. Infect Immun. 2004;72:238-46 pubmed
Drouin S, Corry D, Hollman T, Kildsgaard J, Wetsel R. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J Immunol. 2002;169:5926-33 pubmed

product information

master code :

SEL485

SKU :

SEL485

product name :

Mouse IFN-gamma ELISpot Development Module, 5 Plate

unit size :

1 Kit (for 5 Plates)

target :

IFN-gamma

category :

ELISpot and FluoroSpot Kits

species :

Mouse

gene symbol :

Ifng

kit type :

Quantitative Sandwich ELISA Development Module

assay length :

3 hours 35 mins to 4 hours 50 mins**

USD :

615 USD

alt names :

IFG, IFI, IFNG, IFNgamma, IFN-gamma, Immune interferon, interferon gamma, interferon, gamma

storage :

Store the unopened product at -20 to -70 ░C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.